Neolytica - A QPharma Company Revenue and Competitors

Claim your profile

Morristown, NJ USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Neolytica - A QPharma Company's estimated annual revenue is currently $145k per year.(i)
  • Neolytica - A QPharma Company's estimated revenue per employee is $72,500

Employee Data

  • Neolytica - A QPharma Company has 2 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M37N/AN/AN/A
#2
$54.7M302-4%N/AN/A
#3
$1.3M9N/AN/AN/A
#4
$23.2M160N/AN/AN/A
#5
$20.2M139-26%N/AN/A
#6
$31.9M200-5%N/AN/A
#7
$1.5M10N/AN/AN/A
#8
$23.2M160N/AN/AN/A
#9
$1M11N/AN/AN/A
#10
$0.1M2N/AN/AN/A

A subsidiary of QPharma, Neolytica brings solutions and a portfolio of products that leverage cutting edge technologies like AI and Data Analytics to deliver significant value in strategic and operational aspects of Medical Affairs, Market Access, Commercial Marketing and Commercial Sales. Our offerings portfolio includes: Ti Expert : This technology and consulting solution brings comprehensive access to data about highly qualified and validated medical professionals, including professional spheres of influence, social relationships, and promotional activities. NotifyMe : A Healthcare KOL engagement service with email alerts. An application that enables enterprise-scale social listening and provides actionable alerts on healthcare stakeholders in a desired therapeutic area. Ti Risk : Dependence on Opioid has increased burden on patients, employers, insurers, society, and the health care system. Our product aims to address this by identifying prescribers and patients that are potentially involved in diversion of opioids by following patient journey and prescriber behaviour, along with supplementary secondary research – Real-time and At-risk scoring analysis. For more details, visit - www.neolytica.ai

keywords:N/A

N/A

Total Funding

2

Number of Employees

$145k

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Neolytica - A QPharma Company News

2022-03-22 - QPharma's Neolytica Experiences Explosive Business Growth

QPharma's Neolytica Experiences Explosive Business Growth. Healthcare Analytics Firm Adds Enterprise-Level Clients, Records 270% Growth Over...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A2N/AN/A
#2
$0.4M3N/AN/A
#3
$0.6M4N/AN/A
#4
$2M8N/AN/A
#5
$1.3M9N/AN/A